Medroxyprogesterone acetate-SC is a three-month contraceptive that can be administered by healthcare workers or self-injected after appropriate training
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
First research project, supported by the Gates Foundation, focuses on developing non-hormonal contraceptives for women in low- and middle-income countries
The new cGMP-compliant HPAPI Laboratory is equipped with state-of-the-art isolators designed to meet Occupational Exposure Band 5 (OEB-5) requirements
The company will present new data from across over 20 cancer types and multiple treatment settings at European Society for Medical Oncology Congress 2025
New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain
Takeda will seek an external partner to leverage its cell therapy platform technologies
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
The discussions are expected to pave the way for the creation of a consolidated national knowledge-sharing platform on IT-enabled Ayush services,
Subscribe To Our Newsletter & Stay Updated
